Abdominal Aortitis after Use of Granulocyte Colony-Stimulating Factor

被引:0
|
作者
Giridhar U. Adiga
Dahlia Elkadi
Sandeep K. Malik
Jill D. Fitzpatrick
Stefan Madajewicz
机构
[1] New York Medical College,Department of Oncology, Montefiore Medical Center North Division
[2] Emory University School of Medicine,Department of Hematology and Medical Oncology
[3] Stony Brook University Cancer Center,Emeritus of Medicine
来源
关键词
Abdominal Aortic Aneurysm; Aortic Wall; Pantoprazole; Giant Cell Arteritis; African American Male;
D O I
暂无
中图分类号
学科分类号
摘要
Granulocyte colony-stimulating factor (G-CSF) is a recombinant human glycoprotein that promotes proliferation and differentiation of granulocytic-committed progenitors. It is commonly used to treat neutropenia and is generally well tolerated. Occurrences of rare but serious adverse events in association with the use of G-CSF have been described. We report the case of a 54-year-old male with squamous cell carcinoma of the lung who developed abdominal aortitis following the use of G-CSF. Other possible aetiological conditions were excluded based on laboratory and radiological evaluations. To our knowledge, this represents the second case report demonstrating an association between aortitis and the use of G-CSF.
引用
收藏
页码:821 / 825
页数:4
相关论文
共 50 条
  • [41] DETECTION OF THE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR USING BIOTINYLATED GRANULOCYTE COLONY-STIMULATING FACTOR - PRESENCE OF GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR ON CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS
    SHIMODA, K
    OKAMURA, S
    HARADA, N
    NIHO, Y
    RESEARCH IN EXPERIMENTAL MEDICINE, 1992, 192 (04) : 245 - 255
  • [42] Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF)
    Miller, Edward B.
    Grosu, Roy
    Landau, Zvi
    CLINICAL RHEUMATOLOGY, 2016, 35 (06) : 1655 - 1657
  • [43] Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor
    Shirai, Tsuyoshi
    Komatsu, Hiroka
    Sato, Hiroko
    Fujii, Hiroshi
    Ishii, Tomonori
    Harigae, Hideo
    INTERNAL MEDICINE, 2020, 59 (12) : 1559 - 1563
  • [44] Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy
    Bregni, M
    Siena, S
    DiNicola, M
    Dodero, A
    Peccatori, F
    Ravagnani, F
    Danesini, G
    Laffranchi, A
    Bonadonna, G
    Gianni, AM
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 628 - 635
  • [45] Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats
    Chung, Joonho
    Kim, Moon Hang
    Yoon, Yong Je
    Kim, Kil Hwan
    Park, So Ra
    Choi, Byung Hyune
    JOURNAL OF NEUROSURGERY-SPINE, 2014, 21 (06) : 966 - 973
  • [46] Granulocyte colony-stimulating factor and cytokine release
    Jilma, B
    Pollmächer, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (02) : 220 - 220
  • [47] Cutaneous manifestations of granulocyte colony-stimulating factor
    White, JML
    Mufti, GJ
    Salisbury, JR
    du Vivier, AWP
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (02) : 206 - 207
  • [48] Exacerbation of pseudogout by granulocyte colony-stimulating factor
    Sandor, V
    Hassan, R
    Kohn, E
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (09) : 781 - 781
  • [49] URINARY GRANULOCYTE COLONY-STIMULATING FACTOR IN BILHARZIASIS
    MAHMOUD, LAN
    ROBINSON, WA
    ENTRINGER, MA
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1982, 31 (03): : 518 - 521